BiotechTube
Home/CatalYm/Clinton (Clint) Musil
C(

Clinton (Clint) Musil

Chief Financial Officer and Chief Business Officer

CatalYm

Therapeutic Areas

OncologyImmuno-oncology

CatalYm Pipeline

DrugIndicationPhase
Visugromab (CTL-002)Metastatic Non-squamous Non-Small Cell Lung Cancer (2nd line)Phase 2b

Leadership Team at CatalYm

SC
Scott Clarke
Chief Executive Officer
SR
Sujata Rao
Chief Medical Officer
View full CatalYm profile